Your Status: Logged out Log in

CIBA consumer pharmaceuticals' acutrim: Challenges and opportunities in todays diet industry  

Member rating: No Rating | Words: | Submitted: Tue Oct 12 2004

Page Preview
Preview
Previous 1 of 6 Next

On the left is an image preview of every page of this document, and below are the first 150 words with formatting removed:

CIBA CONSUMER PHARMACEUTICALS' ACUTRIM: CHALLENNGES AND OPPORTUNITIES IN TODAY'S DIET INDUSTRY Ciba Consumer Pharmaceuticals is facing a dilemma to decide whether or not to increase their marketing expenditures on Acutrim, an appetite suppressant. Considering that in the last years, the consumer attitude to this kind of products has been shifting to more natural products and meal replacements and they are very sensitive to new products and fad-oriented, so it is a very volatile industry with low standards of loyalty among its customers and an increase concern of the safety issues about taking a pill to lose weight. Besides those facts, the company has a big competitor, Thompson Medical Company, which has been investing more funds on the advertisement campaigns of their diet pills (Dexatrim). And the overall market for appetite suppressant has been decreasing, because consumers right now are more attend to their life styles, what they eat and their activity...

Get instant access



  • Instant, unlimited access to our documents in full
  • Swap your work for free access, or pay £4.99
  • To see the full version of this document and 145,970 others
Register Now
OR

Receive email updates for this category



  • Simply tell us your email address and receive a weekly Study Help Email for FREE
  • Receive 3 FREE essay views with each email
  • Get all the latest essays from Coursework.Info & discussion from TheStudentRoom.co.uk